Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
HINKS T., CURETON L., KNIGHT R., Wang A., CANE J., BARBER V., BLACK J., DUTTON S., Melhorn J., JABEEN M., Moss P., Garlapati R., Baron T., Johnson G., Cantle F., Clarke D., Elkhodair S., Underwood J., Lasserson D., PAVORD I., Morgan S., RICHARDS D.